RTI Surgical Announces Launch Of Streamline TL Spinal Fixation System – Deformity Instrumentation

ALACHUA, Fla.--(BUSINESS WIRE)--RTI Surgical^® Inc. (RTI) (Nasdaq: RTIX), a leading global surgical implant company, is pleased to announce the launch of the Streamline TL Spinal Fixation System – Deformity Instrumentation for complex adult deformities or curvatures. With a focus on versatility, ease-of-use and surgeon comfort, the Streamline TL deformity instruments bring another level of functionality to RTI Surgical’s advanced pedicle screw system.

“With this addition to our spine portfolio we are very excited to be able to cover an even broader range of surgeon and patient needs.”

The Streamline TL Spinal Fixation System allows a rigid construct to be created in the thoracolumbar spine using pedicle screws, set screws, rods and crosslinks. RTI has continued to expand on the system’s offerings since the initial launch of the system in 2011, adding innovative solutions to address various patient pathologies. The newest addition to the system, the deformity instrumentation, provides surgeons with the resources necessary to perform challenging adult deformity cases.

“Expanding our Streamline TL Spinal Fixation System with these innovative and versatile deformity instruments enhances our ability to compete in the complex deformity market,” said Brian K. Hutchison, president and CEO of RTI Surgical. “With this addition to our spine portfolio we are very excited to be able to cover an even broader range of surgeon and patient needs.”

About RTI Surgical Inc.

RTI Surgical is a leading global surgical implant company providing surgeons with safe biologic, metal and synthetic implants. Committed to delivering a higher standard, RTI’s implants are used in sports medicine, general surgery, spine, orthopedic, trauma and cardiothoracic procedures and are distributed in nearly 50 countries. RTI is headquartered in Alachua, Fla., and has four manufacturing facilities throughout the U.S. and Europe. RTI is accredited in the U.S. by the American Association of Tissue Banks and is a member of AdvaMed. For more information, please visit www.rtix.com.

Forward Looking Statement

This communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s current expectations, estimates and projections about our industry, our management’s beliefs and certain assumptions made by our management. Words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” variations of such words and similar expressions are intended to identify such forward-looking statements. In addition, except for historical information, any statements made in this communication about anticipated financial results, growth rates, new product introductions, future operational improvements and results or regulatory actions or approvals or changes to agreements with distributors also are forward-looking statements. These statements are not guarantees of future performance and are subject to risks and uncertainties, including the risks described in public filings with the U.S. Securities and Exchange Commission (SEC). Our actual results may differ materially from the anticipated results reflected in these forward-looking statements. Copies of the company’s SEC filings may be obtained by contacting the company or the SEC or by visiting RTI’s website at www.rtix.com or the SEC’s website at www.sec.gov.